BACKGROUND: In the current study, the authors evaluated the impact of implementing The Paris System for Reporting Urinary Cytology (PSRUC) on the prevalence of various cytological categories and their association with a subsequent diagnosis of high-grade urothelial carcinoma (HGUC). METHODS: A comparative study was conducted over the 6-month period before PSRUC implementation (2013), including 1653 patients and 2371 specimens versus a 6-month period after implementation of the PSRUC (2016), including 1478 patients and 2392 specimens. The following cytological categories were correlated with the subsequent biopsy result when available (355 cases): negative for HGUC (NHGUC), atypical urothelial cells (AUC), suspicious for HGUC, and HGUC. RESULTS: Although 18.6% of specimens were diagnosed as AUC in 2013, the percentage was 14.4% in 2016 (P <.0001). Concurrently, the prevalence of the "benign" category increased from 2013 to 2016 (75.4% vs 80%; P <.0001). After implementation of the PSRUC, there was no significant change noted with regard to the association between the categories of NHGUC, suspicious for HGUC, and HGUC and a subsequent HGUC biopsy diagnosis. However, the predictive value of an AUC diagnosis increased from 28.3% to 46.1% (P 5.077). Most important, after the implementation of the PSRUC, there was a significant difference noted with regard to the predictive association for HGUC between the NHGUC and AUC groups (13.6% vs 46.1%; P 5.003), a difference that was not found to be statistically significant before implementation of the PSRUC (18% vs 28.3%; P 5.175). CONCLUSIONS: There was a much higher risk of HGUC conveyed by AUC cytology after implementation of the PSRUC, justifying more aggressive investigations of patients who receive an AUC diagnosis.
INTRODUCTION
Urine cytology is an essential method for the surveillance and detection of urothelial neoplasms, with its strength being its specificity for the detection of high-grade urothelial carcinoma (HGUC). In 2004, the Papanicolaou Society of Cytopathology developed a urine cytology classification scheme that included a category of "atypical urothelial cells" (AUC) and further subclassified this atypical group into reactive or neoplastic. However, this classification scheme was lacking in specific and reproducible criteria for the recommended atypical categories. To meet this need, various institutions independently developed in-house diagnostic criteria as well as subclassifications for the "atypical" category, such as "AUCs favor a reactive process versus AUCs unclear whether reactive or neoplastic," "AUCs of undetermined significance versus AUCs-cannot rule out high-grade carcinoma," and "AUCs favor a reactive process versus AUCs favor neoplastic." The wide variation in the use and criteria for the atypical category resulted in significant differences in the interinstitutional rates of the AUC diagnosis (range, 2%-31%), as well as its association with subsequent histologic diagnoses of HGUC (range, 8.3%-37.5%). [1] [2] [3] [4] [5] [6] The unpredictable nature of the atypical category contributed to the inclination of many urologists to treat AUC cases similarly to "negative" cases, thereby rendering it a clinically irrelevant diagnostic category. It is within this context that The Paris System for Reporting Urinary Cytology (PSRUC) was developed as a concerted and multidisciplinary effort to define strict criteria for different categories, especially the atypical category, and to restrict its use to cases in which there is a true, increased probability of HGUC. 7 This new system proposes 4 major categories for urine cytology: 1) negative for HGUC (NHGUC); 2) AUC; 3) suspicious for HGUC (SHGUC); and 4) positive for HGUC (HGUC). Specific goals of the PSRUC include the reduction of the prevalence of the "atypical" category and the simultaneous increase in its predictive association with HGUC on surgical follow-up and histologic diagnosis. Inclusion criteria for AUC in the PSRUC focus on nuclear atypia, which is more likely associated with HGUC, such as hyperchromasia, irregular nuclear contours, and coarse chromatin. Various reactive conditions such as urolithiasis and polyomavirus infection no longer are included in the AUC category and instead are classified as NHGUC. The study institution adopted the PSRUC in January 2016. Before this, urine cytology results were classified into 5 categories: 1) negative; 2) atypical urothelial cells favoring a reactive process (AR); 3) atypical urothelial cells unclear if reactive or neoplastic process (AU); 4) suspicious for HGUC; and 5) positive for HGUC. The current study evaluates the impact of implementing the new PSRUC by capturing data from 2013 and 2016, with 2013 serving as a control to reflect urine cytology results before implementation of the PSRUC. The change in the prevalence of each diagnostic category is evaluated by comparing the 2 years. In addition, we correlated cytology diagnoses with subsequent histologic follow-up results to evaluate the predictive association of the atypical category for HGUC, both before and after implementation of the PSRUC. For the sake of comparison with 2016, the AU and AR categories of 2013 were collapsed into 1 atypical category (AUC).
MATERIALS AND METHODS

Case Selection
Using the laboratory's electronic records system, urine cytology specimens were retrieved and examined over a 6-month period in 2013 as well over a 6-month period in 2016.
Based on this list, we then searched for all subsequent surgical specimen reports associated with each case up to 1 year later. Age, date of collection, and type of specimen were recorded for each cytology specimen. No slides were retrospectively reviewed, and the study used all original cytological and histological diagnoses.
Cytological Preparation
Voided urine specimens were prepared as ThinPrep slides (Hologic, Marlborough, Massachusetts) whereas all other types of urine specimens were prepared using conventional methods such as centrifugation and smear preparation or Cytospin (Thermo Fisher Scientific, Waltham, Massachusetts). Papanicolaou staining was used for all slides.
Cytological Criteria
In 2013, before implementation of the PSRUC, the diagnostic categories of urine cytology at the study institution included the following: benign (including instrumentation effects and reactive urothelial cells); AR; AU; suspicious for urothelial carcinoma; and urothelial carcinoma. The 4 pathologists responsible for signing out cytology cases all received cytopathology subspecialty training and were familiar with the institutional criteria for subclassifying the atypical urothelial category into the AR versus AU categories. Urine cytology cases in voided specimens were considered atypical when the nuclear-to-cytoplasmic (N/C) ratio was > 50%. Once in the atypical category, the AR designation was given to cases in which the cells were in clusters and had bubbly cytoplasm with a smooth and intact nuclear membrane, often with a conspicuous nucleolus (Fig. 1) . The AU category was reserved for nondegenerated or degenerated AUCs that had intact and irregular nuclear membranes with clumpy chromatin or a dark chromatin pattern (Fig. 2) . The majority of cases classified as AU featured cells that appeared similar to the "pseudodegenerated" cells as described by Renshaw. 8 The method of urine collection also was considered; the degree of nuclear atypia required for calling a case atypical was higher in instrumented specimens compared with voided specimens. It is interesting to note that for the Original Article purposes of the current study, the 2013 categories of AR and AU were combined into 1 AUC category to facilitate comparison with the AUC category in 2016. The diagnostic criteria for the original SHGUC and HGUC categories were close but not similar to those provided in the PSRUC. As an example, we always required 10 cells as a quantitative cutoff between the 2 categories. We also included severely atypical degenerated cells in our original SHGUC category. In January 2016, the study institution adopted the PSRUC, which proposed the diagnostic categories of NHGUC, AUC, SHGUC, and HGUC. For the purposes of the current study, the "low-grade urothelial neoplasia" cytology category was excluded. As per the PSRUC, 7 the NHGUC group included cases that either had benign cytologic features or harbored mild atypical changes in a clinical context known to cause cytologic changes, such as urolithiasis, polyomavirus infection, irradiation, chemotherapy, and instrumentation. Cases containing tissue fragments but without cytologic atypia were considered as NHGUC, even if such fragments were present in voided specimens. In addition, cells with an N/C ratio >0.5 were considered to be negative, provided that no other abnormal cytologic features were present. The PSRUC AUC diagnosis was reserved for nondegenerated, nonsuperficial urothelial cells with an increased N/C ratio (>0.5) and only 1 of the following features: hyperchromasia, coarse chromatin, or irregular nuclear membranes (Fig. 3) . The AUC diagnosis also allowed for cases with degenerated cells, in which 1 of the previously mentioned cytomorphological criteria were met in addition to an N/C ratio >0.5. However, degenerated changes were not allowed in the diagnostic criteria of the SHGUC and HGUC categories. As proposed by the PSRUC, cells within the SHGUC category are nondegenerated and nonsuperficial urothelial cells demonstrating an N/C ratio of >0.7, moderate to severe hyperchromasia, and at least 1 of the 2 following features: clumpy irregular chromatin or markedly irregular nuclear membranes (Fig. 4) . In comparison, the HGUC category includes nondegenerated and nonsuperficial urothelial cells demonstrating an N/C ratio of >0.7, moderate to severe hyperchromasia, clumpy irregular chromatin, and markedly irregular nuclear membranes. Nuclear overlap, comet, India-ink, and apoptotic cells and prominent nucleoli also can be seen. According to the PSRUC, "a cellular cytologic urine specimen with a minimum of 5-10 viable malignant cells will qualify as HGUC with the specimen's type and comfort level of pathologist being contributing factors to the minimal number of abnormal cells required for a more definitive diagnosis of malignancy."
Cytology-Histology Correlation
Cytology results were correlated with their histologic outcome, which was divided as follows: 1 indicated benign; 2 indicated low-grade urothelial neoplasm (including Figure 1 . Cell cluster demonstrating an increased nuclear-tocytoplasmic ratio (>50%); pale, evenly distributed chromatin; overall smooth nuclear membranes; and visible nucleoli. Previously, this cluster would have been labeled as "atypical urothelial cells, favor a reactive process" in the study institution. Using The Paris System for Reporting Urinary Cytology criteria, the case would remain in the category of "negative for high-grade urothelial carcinoma" (voided specimen; ThinPrep, Papanicolaou stain, original magnification 3600). One degenerated cell demonstrating a high nuclear-to-cytoplasmic ratio, nuclear hyperchromasia, thickened and discontinuous nuclear membrane, clumpy chromatin, and a dark India-ink chromatin pattern. This case was labeled as "atypical urothelial cells, unclear if reactive or neoplastic." According to the Paris System, a diagnosis of "atypical urothelial cells" is appropriate in such cases (voided specimen; ThinPrep, Papanicolaou stain, original magnification 3600).
papillary neoplasm of low malignant potential and lowgrade papillary urothelial carcinoma); 3 indicated HGUC (including noninvasive high-grade papillary urothelial carcinoma, invasive urothelial carcinoma, and urothelial carcinoma in situ); and 4 indicated high-grade malignant (including HGUCs and nonurothelial neoplasms, such as melanoma). The cytology-histology correlation was defined as the correlation between a cytology case and the corresponding biopsy; if >1 biopsy was available, the biopsy performed closest to the date of the urine collection was used. When >1 cytology specimen was collected before the biopsy was performed, the cytology-histologic correlative event was made between histology and the most abnormal cytology result, provided that it was rendered within 1 year from the follow-up biopsy. We selected a period of 1 year as the maximum interval permitted between cytology and histology to assess concordance. We believe that a longer interval may allow for new tumors to arise in the follow-up histology, such that these tumors were not present when the index cytology specimen was obtained. The same approach has been used in previous studies, 1 and was believed to be clinically valid for the urologists at the study institution. Biopsy and the obtained histology also were chosen as the endpoints in the cytologyhistology correlative event. Thus, in cases in which there was >1 biopsy separated by cytology specimens, the number of correlative events was equal to the number of biopsies. It is interesting to note that when cytology and biopsy were obtained at the same time, the cytopathologist was not aware of the biopsy result because the cytology and histology specimens are sent to 2 separate teams of pathologists, with generally faster turnaround time for cytology cases in comparison with surgical cases.
RESULTS
Over a 6-month period in 2013 (before implementation of the PSRUC), a total of 1653 patients and 2371 specimens were included, with 188 specimens having histologic follow-up. A total of 2039 samples (86%) were voided urine and 332 (14%) were instrumented urine. Approximately 8% of the total cytology specimens (134 specimens) had subsequent biopsy follow-up. Of those, 71% were voided and 29% were instrumented specimens. Over a 6-month period in 2016 (after implementation of the PSRUC), a total of 1478 patients and 2392 specimens were included, with 167 specimens having histologic follow-up. A total of 2113 (88%) samples were from voided urine and 279 (12%) were instrumented urine specimens. Approximately 7% of the total cytology specimens (167 specimens) had subsequent biopsy follow- Figure 3 . One cluster of nonsuperficial and nondegenerated cells demonstrating an increased nuclear-to-cytoplasmic ratio and irregular chromatin pattern but only mild hyperchromasia. This case is best labeled as "atypical urothelial cells" according to The Paris System for Reporting Urinary Cytology due to the absence of severe hyperchromasia. Similar cases were grouped under the "atypical urothelial cells, unclear if reactive or neoplastic" category using our original system (voided specimen, ThinPrep, original magnification 3600). One single nonsuperficial and nondegenerated urothelial cell demonstrating a high nuclear-to-cytoplasmic ratio, severe hyperchromasia, and an irregular clumpy chromatin pattern. This case should be labeled as "suspicious for highgrade urothelial carcinoma" using The Paris System for Reporting Urinary Cytology, provided there are 10 cells with similar cytological features in the specimen; otherwise a diagnosis of "high-grade urothelial carcinoma" would be appropriate. A similar approach was used in the study laboratory before implementation of The Paris System for Reporting Urinary Cytology (voided specimen; ThinPrep, Papanicolaou stain, original magnification 3600).
up. Of those, 72% were voided and 28% were instrumented specimens.
Prevalence of Diagnostic Categories
Although 18.6% of cytology specimens were diagnosed as "atypical" in 2013, this percentage was 14.4% in 2016, demonstrating a decrease of 4.2% (P < .0001) in the overall prevalence of this category. Concurrently, the overall prevalence of the "benign" category was found to have increased from 2013 to 2016 (75.4% vs 80%; P < .0001). The prevalence of the "suspicious" and "positive for HGUC" categories demonstrated no significant change between 2013 and 2016 (Table 1) . To evaluate the impact of specimen type on the noted prevalence changes, we performed the same analysis by dividing specimens into voided and instrumented specimens. Within voided specimens, the prevalence of NHGUC significantly increased by 6.5% between 2013 and 2016 (74.5% vs 81%), whereas the prevalence of AUC significantly decreased by 5.5% (20% vs 14.5%). There was no significant change noted with regard to the percentages of SHGUC and HGUC between 2013 and 2016. In comparison, no significant changes in the prevalence of various diagnostic categories were observed over time in instrumented specimens. However, there was a noted decrease in the diagnosis of NHGUC (81% vs 75.6%; P 5 .139) and an increase in the AUC category (10.2% vs 13.6%; P 5 .533). The percentage of the SHGUC and HGUC categories remained similar between 2013 and 2016 ( Table 3 , in which 3 main observations could be made. The first was the notable increase in the predictive value of an AUC diagnosis from 28.3% in 2013 to 46.1% in 2016. The second was the decrease in the predictive value of an NHGUC diagnosis from 18% in 2013 to 13.6% in 2016. The third was the lack of a significant predictive difference between the benign and AUC categories in 2013 (P 5 .175) in comparison with 2016, for which this difference became statistically significant (P 5 .0003).
DISCUSSION
The current study is the source of several interesting findings related to the impact of implementing the PSRUC on both the prevalence of cytological categories and their association with subsequent HGUC. At the prevalence level, it was noted that the rates of the SHGUC and HGUC categories did not change between 2013 and 2016. This most likely is due to the fact that the diagnostic criteria used at the study institution for these 2 categories before the PSRUC was implemented were very similar to those of the PSRUC. In comparison, and in keeping with 3 previous retrospective studies, [4] [5] [6] implementation of the PSRUC significantly reduced the overall prevalence of AUC diagnoses while significantly increasing the prevalence of the NHUGC category at the study institution. It is interesting to note that the decrease in the rate of AUC was not evenly distributed when analyzing the data according to specimen type. In fact, it was shown that it resulted from a significant reduction only among voided specimens (which constitute approximately 86% of specimens received in the study laboratory), whereas reverse trends were noted in instrumented specimens. The decreasing prevalence of AUC cases and the increasing number of NHGUC diagnoses in voided urine are likely linked to the application of new strict criteria for the AUC category. Cells clusters in the absence of atypical cytology and polyoma-like changes in the absence of a known history of immunosuppression all are situations in which we would have rendered a diagnosis of AUC in 2013 but not in 2016. Indeed, in 2013, a high N/C ratio (>50%) was sufficient in itself to designate a cell as "atypical," whereas one additional abnormal feature is required using the PSRUC. Similarly, it is probable that many of the degenerated cells with high N/C ratios encountered in voided specimens that were labeled as AUC in 2013 would be considered benign using the PSRUC criteria. In instrumented specimens, a reverse trend in the prevalence of NHGUC and AUC was noted, although it did not reach statistical significance. However, this observation is limited by the small percentage of instrumented specimens in the study institution (14%).
Whether the difference in the specimen preparation technique used at the study institution (ThinPrep in voided specimens vs cytospin and other conventional techniques in instrumented specimens) contributes to this noted difference or whether it is reflective of a criteria-related issue remains to be determined and will be explored in future larger cohorts. It is interesting to note that, in a recent study by Cowan et al, 9 urine specimens with subsequent histological diagnoses of HGUC were retrieved and retrospectively reviewed for cytomorphological atypia as defined by the PSRUC. The sampling method used on the urine specimen was divided between voided, washing, and catheterized. The authors noted an increased tendency for instrumented specimens (ie, washing and catheterized specimens) to demonstrate irregular nuclear borders (78% in voided vs 89% in washing and catheterized specimens). Therefore, the authors suggested that instrumentation artifacts tend to enhance nuclear border irregularities. 9 The second important finding of the current study was the significant association between a cytological diagnosis of AUC after implementation of the PSRUC and the subsequent detection of HGUC (predictive value of 46.1%) in comparison with a weaker association in 2013 (predictive value of 28.3%). Similarly, a smaller number of histologically low-grade urothelial lesions were labeled as AUC in 2016 in comparison with 2013 (26.2% vs 42.6%, respectively). It is interesting to note that before the implementation of the PSRUC, the NHGUC and AUC categories were not significantly different with regard to their predictive association for HGUC (18% vs 28.3%; P 5 .175), whereas the difference became significant in 2016. This is an important change because urologists in the study institution used and continue to approach and manage AUC diagnoses as benign provided that cystoscopy and upper tract imaging results are unremarkable, and generally reserve more aggressive investigations only for those cases diagnosed as SHGUC or HGUC. By applying the PSRUC criteria, the clinically significant threshold moved from SHGUC to AUC, rendering the latter a more meaningful diagnosis. If confirmed by other studies, the PSRUC will have succeeded in one of its major objectives: making the AUC a clinically valid category that can be incorporated into the workup and therapeutic algorithms similar to the way the SHGUC or HGUC categories currently are. Although recent studies related to the PSRUC already have been conducted, we believe the current study is unique in that it reflects the validity of this new system within a prospective context of real-life practice, rather than being of a retrospective nature. [9] [10] [11] For example, our group previously reported a lower number of cases being assigned to the AUC category (26% vs 39%) and a stronger association with a biopsy diagnosis of HGUC (53% vs 33%) using the PSRUC criteria. However, that retrospective study included only 124 patients and suffered from selection bias because the included cases were restricted to those having a biopsy follow-up. Therefore, the rates of "atypia" were not representative of those of the study laboratory overall. 11 A subsequent study by Malviya et al with the same design 10 and including 176 cases reported a decreasing rate of AUC from 11.9% to 5.1% using the PSRUC criteria. In their hands, the PSRUC had a sensitivity of 95%, a specificity of 66.6%, and a positive predictive value of 86.3%. 10 Recently, Cowan et al 9 evaluated the PSRUC criteria of the HGUC category by re-examining the cytology slides of 112 patients with a subsequent diagnosis of HGUC. By using the PSRUC, they were able to reclassify approximately 40% of indeterminate specimens into a higher risk category, resulting in improved risk stratification and confirming the validity of the PSRUC. However, Cowan et al applied stringent diagnostic criteria by requiring all 4 cytomorphological criteria (N/C ratio of > 0.7, moderate to severe hyperchromasia, clumpy irregular chromatin, and markedly irregular nuclear membranes) to diagnose HGUC on cytology. 9 Although the PSRUC states that HGUC cytology "usually" demonstrates all 4 criteria whereas the SHGUC can be diagnosed with only 3 criteria, the emphasis is placed more on the quantitative rather than qualitative characteristics in the distinction between the SHGUC and HGUC categories. 12 The findings of the current study demonstrate that implementing the PSRUC results in a decrease in the rate of the AUC category and an increase in its prediction of subsequent HGUC, thereby rendering it a clinically meaningful cytological category.
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